umentation of seizure frequency affects therapeutic decisions in IFCN guidelineworking group as ‘‘high level” evidence in GRADE
dailyclinicalpractice,questioningthereliabilityoflargedrugstud- terms, while phase 2 studies were categorized as ‘‘moderate evi-
ies, which are typically based on patient-reported seizure fre- dence”.Inthisreviewpaper,wefollowedthesameprinciples. In
quency [9]. Studies in the Epilepsy Monitoring Units (EMU), thisreviewpaper,wesummarizeandciteallphases3and4stud-
wherethegoldstandardforseizurefrequencywasavailablefrom iespublishedsincetheclinicalpracticeguideline.Phase-2studies,